Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge
about
IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infectionImmunotherapy for tularemiaHow specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depthB-1 Cell Heterogeneity and the Regulation of Natural and Antigen-Induced IgM ProductionEffective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigensNovel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strainRole of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity.Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection.Bronchus-associated lymphoid tissue (BALT) and survival in a vaccine mouse model of tularemia.Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection.A variety of novel lipid A structures obtained from Francisella tularensis live vaccine strainLong-lived bone marrow plasma cells are induced early in response to T cell-independent or T cell-dependent antigens.A mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS.Distinct progenitors for B-1 and B-2 cells are present in adult mouse spleen.Thermostable cross-protective subunit vaccine against Brucella speciesIdentification of a live attenuated vaccine candidate for tularemia prophylaxisAntibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strainsIsolation and mutagenesis of a capsule-like complex (CLC) from Francisella tularensis, and contribution of the CLC to F. tularensis virulence in miceActivation of B cells by a dendritic cell-targeted oral vaccine.The role of B cells and humoral immunity in Mycobacterium tuberculosis infectionProduction of anti-LPS IgM by B1a B cells depends on IL-1β and is protective against lung infection with Francisella tularensis LVSDownmodulation of vaccine-induced immunity and protection against the intracellular bacterium Francisella tularensis by the inhibitory receptor FcγRIIB.Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice.Generation of B cell memory to the bacterial polysaccharide alpha-1,3 dextran.Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.Role of Francisella lipid A phosphate modification in virulence and long-term protective immune responses.Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine.Antigen-specific antibody responses in B-1a and their relationship to natural immunityAntigen-specific memory in B-1a and its relationship to natural immunity.New insights into heterogeneity of peritoneal B-1a cells.Characteristics of natural antibody-secreting cells.Molecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection.Expression of plasma cell alloantigen 1 defines layered development of B-1a B-cell subsets with distinct innate-like functions.Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.Circulating Biomarkers of Gut Barrier Function: Correlates and Nonresponse to Calcium Supplementation among Colon Adenoma Patients.IL-15 temporally reorients IL-10 biased B-1a cells toward IL-12 expression.B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses.Activities of Murine Peripheral Blood Lymphocytes Provide Immune Correlates That Predict Francisella tularensis Vaccine Efficacy
P2860
Q24631904-CB3D666D-5F95-4E95-9AF1-6C6E62C66621Q26864945-4CEE1B26-049F-4F8D-AB99-B768ED664A7AQ27026728-09F94CB9-7EB5-4DDF-84F9-2B3113C85ED0Q28078102-6DF271BA-6018-4506-84A0-E8B82B5B094AQ28474115-D682595F-2D81-4B48-A317-155975AD56FFQ30411506-7F6CCC16-2F2B-4C0B-BB52-4D29F3ADB5CCQ30424747-43AC065D-C753-414E-A0ED-FB52D4C08A97Q30559887-12B24084-70CC-4786-AA6E-F7DFBD72304AQ31027494-228BB3E3-6D70-4C88-8844-9029DECA2BA1Q33524893-073D8E1C-F70E-4B55-B902-55F8357D3B72Q33618911-1BD2CE30-B225-4846-A715-EA5E2FD526F6Q33631177-38FB3019-5EFD-4B70-8499-039AB4C5880FQ33944170-AF8E080F-2BBC-4A52-ADF0-B3A1212582A2Q34270556-769D48AF-004C-4307-A090-24486645C79FQ34500312-BC32A8FB-C94F-419C-9A27-597E17287542Q34582896-61E4F081-D72C-46C4-9DDF-45BC99E02A54Q34593053-06D9E3BB-9CCC-46DD-9816-1931D357F451Q34684536-15788A66-FE70-401D-BA88-D8E7F0C09C37Q34740339-A56E4022-B1E0-4B02-937F-9852B5E7B920Q34841347-49B814AA-517F-4200-9A08-9762F0C26B81Q34979404-F845FA2F-6A6E-4996-B6D7-CE1EEC6DF86EQ35039807-D28FFAA7-9FCC-4B7D-9845-A1B73267800BQ35175319-7BE510CF-3708-4CCD-BBA3-1A59ECEE4E6AQ35563406-0EE1B991-2A80-4357-B22D-8F5E9EB49824Q35606536-4C307508-2B34-46A5-BC66-3439B0846327Q35607247-1B548F13-358C-4A04-A02F-09B0E37523E2Q35670540-A5A68A2C-E339-4829-8793-E0D2FF7A831EQ35805338-498F639F-2A59-460F-9E2B-8DE81F94FD75Q35808608-CABBDED5-56EF-4CD9-B755-BA2E697414A5Q35887152-56BB987A-4A8D-404E-9225-CF1CE31F0E36Q35887198-657CEA9E-E021-48D4-AE94-ABFF4B2ACC5BQ36296344-408C42D5-C759-4F17-8C20-E6F3E106966DQ36373409-912DAC24-73A1-49E0-B1EE-CE6017C51BF7Q36456615-49A3AA71-52D5-42FB-B9C0-41614412A60CQ36471271-CFA2280F-CE68-4EA9-A39F-8B27E86CA523Q36558802-CBA8CB0B-6DB0-4132-A1C2-BEFAE5446DE4Q36619670-E0DF5D79-EBD7-4FEC-BF80-0526A5D4983CQ36674429-BB0DD520-F72B-4F5E-9371-6823B826F9C2Q36675682-4F6D38FA-C754-4333-8467-9B4A20C04C4EQ36727982-FDACB759-25AF-424A-BAAB-2E41D9EF7EF1
P2860
Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antigen-specific B-1a antibodi ...... st F. tularensis LVS challenge
@en
Antigen-specific B-1a antibodi ...... t F. tularensis LVS challenge.
@nl
type
label
Antigen-specific B-1a antibodi ...... st F. tularensis LVS challenge
@en
Antigen-specific B-1a antibodi ...... t F. tularensis LVS challenge.
@nl
prefLabel
Antigen-specific B-1a antibodi ...... st F. tularensis LVS challenge
@en
Antigen-specific B-1a antibodi ...... t F. tularensis LVS challenge.
@nl
P2093
P2860
P356
P1476
Antigen-specific B-1a antibodi ...... st F. tularensis LVS challenge
@en
P2093
Ellen T Fernandez
Karen L Elkins
Leah E Cole
Leonard A Herzenberg
Leonore A Herzenberg
Mark J Shlomchik
Nilofer Qureshi
Stefanie N Vogel
P2860
P304
P356
10.1073/PNAS.0813411106
P407
P577
2009-02-26T00:00:00Z